ArticleThe Lancet. Oncology2013
Dasatinib and docetaxel in advanced prostate cancer.
Primo N Lara et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleThe Lancet. Oncology2013
Primo N Lara et al.PubMed ↗Publisher ↗
No numbers read from the abstract.